AnGes

2 Decision Makers · 2 Verified Contacts

📍 Tokyo, Tokyo, JapanPharmaceuticals🗓 Est. 1999👥 101–250 employees

About AnGes

AnGes is a biopharmaceutical company with a mission to provide patients, especially those suffering from disease.

Leadership & Decision Makers

Contact details of 2 AnGes decision makers

EI Yamada

President & CEO

Andy G. Hinson

Senior Director of Clinical Development

General Emails

General company emails, e.g. customer support lines

    inquiry-mpsvi@anges.co.jp

    Unclassified inbox

    sasaki@anges.co.jp

    Unclassified inbox

    acrl@anges.co.jp

    Unclassified inbox

    nsato@anges.co.jp

    Unclassified inbox

Similar Companies like AnGes

Sorrento Therapeutics

sorrentotherapeutics.com
Pharmaceuticals · San Diego, CA · Est. 2006 · 101–250 employees · $500M–$1B

HQ: San Diego, CA

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Indivior

indivior.com
Biotechnology · Richmond, VA · Est. 2014 · 501–1000 employees

HQ: Richmond, VA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 31/07/2025

Tokyo, Tokyo, Japan

Specialization: Biopharmaceutical, Genetics,
Legal Name: AnGes Inc.
Business Type: Public
Employees: 101-250
Rounds: Seed
Founded Date: Dec 17, 1999
Number of Exits: 1
Company Type: For Profit
Stock Symbol: TYO:4563
Operating Status: Active
Last Funding Type: Seed
Last Investment Activity: Jan 18, 2024
Investments Activity: Jan 18, 2024 Dec 15, 2020 Dec 15, 2020

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.